Cargando…

Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells

BACKGROUND: Recent studies have highlighted that uncoupling of sarco-/endoplasmic reticulum Ca(2+)-ATPase (SERCA) by sarcolipin (SLN) increases ATP consumption and contributes to heat liberation. Exploiting this thermogenic mechanism in skeletal muscle may provide an attractive strategy to counterac...

Descripción completa

Detalles Bibliográficos
Autores principales: Mengeste, Abel M., Katare, Parmeshwar, Dalmao Fernandez, Andrea, Lund, Jenny, Bakke, Hege G., Baker, David, Bartesaghi, Stefano, Peng, Xiao-Rong, Rustan, Arild C., Thoresen, G. Hege, Kase, Eili Tranheim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270280/
https://www.ncbi.nlm.nih.gov/pubmed/35364719
http://dx.doi.org/10.1007/s11033-022-07387-0
_version_ 1784744427841912832
author Mengeste, Abel M.
Katare, Parmeshwar
Dalmao Fernandez, Andrea
Lund, Jenny
Bakke, Hege G.
Baker, David
Bartesaghi, Stefano
Peng, Xiao-Rong
Rustan, Arild C.
Thoresen, G. Hege
Kase, Eili Tranheim
author_facet Mengeste, Abel M.
Katare, Parmeshwar
Dalmao Fernandez, Andrea
Lund, Jenny
Bakke, Hege G.
Baker, David
Bartesaghi, Stefano
Peng, Xiao-Rong
Rustan, Arild C.
Thoresen, G. Hege
Kase, Eili Tranheim
author_sort Mengeste, Abel M.
collection PubMed
description BACKGROUND: Recent studies have highlighted that uncoupling of sarco-/endoplasmic reticulum Ca(2+)-ATPase (SERCA) by sarcolipin (SLN) increases ATP consumption and contributes to heat liberation. Exploiting this thermogenic mechanism in skeletal muscle may provide an attractive strategy to counteract obesity and associated metabolic disorders. In the present study, we have investigated the role of SLN on substrate metabolism in human skeletal muscle cells. METHODS AND RESULTS: After generation of skeletal muscle cells with stable SLN knockdown (SLN-KD), cell viability, glucose and oleic acid (OA) metabolism, mitochondrial function, as well as gene expressions were determined. Depletion of SLN did not influence cell viability. However, glucose and OA oxidation were diminished in SLN-KD cells compared to control myotubes. Basal respiration measured by respirometry was also observed to be reduced in cells with SLN-KD. The metabolic perturbation in SLN-KD cells was reflected by reduced gene expression levels of peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α) and forkhead box O1 (FOXO1). Furthermore, accumulation of OA was increased in cells with SLN-KD compared to control cells. These effects were accompanied by increased lipid formation and incorporation of OA into complex lipids. Additionally, formation of complex lipids and free fatty acid from de novo lipogenesis with acetate as substrate was enhanced in SLN-KD cells. Detection of lipid droplets using Oil red O staining also showed increased lipid accumulation in SLN-KD cells. CONCLUSIONS: Overall, our study sheds light on the importance of SLN in maintaining metabolic homeostasis in human skeletal muscle. Findings from the current study suggest that therapeutic strategies involving SLN-mediated futile cycling of SERCA might have significant implications in the treatment of obesity and associated metabolic disorders. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9270280
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-92702802022-07-10 Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells Mengeste, Abel M. Katare, Parmeshwar Dalmao Fernandez, Andrea Lund, Jenny Bakke, Hege G. Baker, David Bartesaghi, Stefano Peng, Xiao-Rong Rustan, Arild C. Thoresen, G. Hege Kase, Eili Tranheim Mol Biol Rep Original Article BACKGROUND: Recent studies have highlighted that uncoupling of sarco-/endoplasmic reticulum Ca(2+)-ATPase (SERCA) by sarcolipin (SLN) increases ATP consumption and contributes to heat liberation. Exploiting this thermogenic mechanism in skeletal muscle may provide an attractive strategy to counteract obesity and associated metabolic disorders. In the present study, we have investigated the role of SLN on substrate metabolism in human skeletal muscle cells. METHODS AND RESULTS: After generation of skeletal muscle cells with stable SLN knockdown (SLN-KD), cell viability, glucose and oleic acid (OA) metabolism, mitochondrial function, as well as gene expressions were determined. Depletion of SLN did not influence cell viability. However, glucose and OA oxidation were diminished in SLN-KD cells compared to control myotubes. Basal respiration measured by respirometry was also observed to be reduced in cells with SLN-KD. The metabolic perturbation in SLN-KD cells was reflected by reduced gene expression levels of peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α) and forkhead box O1 (FOXO1). Furthermore, accumulation of OA was increased in cells with SLN-KD compared to control cells. These effects were accompanied by increased lipid formation and incorporation of OA into complex lipids. Additionally, formation of complex lipids and free fatty acid from de novo lipogenesis with acetate as substrate was enhanced in SLN-KD cells. Detection of lipid droplets using Oil red O staining also showed increased lipid accumulation in SLN-KD cells. CONCLUSIONS: Overall, our study sheds light on the importance of SLN in maintaining metabolic homeostasis in human skeletal muscle. Findings from the current study suggest that therapeutic strategies involving SLN-mediated futile cycling of SERCA might have significant implications in the treatment of obesity and associated metabolic disorders. GRAPHICAL ABSTRACT: [Image: see text] Springer Netherlands 2022-04-02 2022 /pmc/articles/PMC9270280/ /pubmed/35364719 http://dx.doi.org/10.1007/s11033-022-07387-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Mengeste, Abel M.
Katare, Parmeshwar
Dalmao Fernandez, Andrea
Lund, Jenny
Bakke, Hege G.
Baker, David
Bartesaghi, Stefano
Peng, Xiao-Rong
Rustan, Arild C.
Thoresen, G. Hege
Kase, Eili Tranheim
Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
title Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
title_full Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
title_fullStr Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
title_full_unstemmed Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
title_short Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
title_sort knockdown of sarcolipin (sln) impairs substrate utilization in human skeletal muscle cells
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270280/
https://www.ncbi.nlm.nih.gov/pubmed/35364719
http://dx.doi.org/10.1007/s11033-022-07387-0
work_keys_str_mv AT mengesteabelm knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT katareparmeshwar knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT dalmaofernandezandrea knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT lundjenny knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT bakkehegeg knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT bakerdavid knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT bartesaghistefano knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT pengxiaorong knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT rustanarildc knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT thoresenghege knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells
AT kaseeilitranheim knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells